These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24032478)

  • 1. A(2A) adenosine receptors and Parkinson's disease severity.
    Casetta I; Vincenzi F; Bencivelli D; Corciulo C; Gentile M; Granieri E; Borea PA; Varani K
    Acta Neurol Scand; 2014 Apr; 129(4):276-81. PubMed ID: 24032478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.
    Varani K; Vincenzi F; Tosi A; Gessi S; Casetta I; Granieri G; Fazio P; Leung E; MacLennan S; Granieri E; Borea PA
    FASEB J; 2010 Feb; 24(2):587-98. PubMed ID: 19776336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated.
    Vincenzi F; Corciulo C; Targa M; Merighi S; Gessi S; Casetta I; Gentile M; Granieri E; Borea PA; Varani K
    Eur J Immunol; 2013 Aug; 43(8):2206-16. PubMed ID: 23661562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
    Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
    Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A2A receptors and Parkinson's disease.
    Morelli M; Carta AR; Jenner P
    Handb Exp Pharmacol; 2009; (193):589-615. PubMed ID: 19639294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
    Morelli M; Di Paolo T; Wardas J; Calon F; Xiao D; Schwarzschild MA
    Prog Neurobiol; 2007 Dec; 83(5):293-309. PubMed ID: 17826884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
    Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
    Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
    Martini C; Tuscano D; Trincavelli ML; Cerrai E; Bianchi M; Ciapparelli A; Alessio L; Novelli L; Catena M; Lucacchini A; Cassano GB; Dell'Osso L
    J Psychiatr Res; 2006 Feb; 40(1):81-8. PubMed ID: 16431220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation regulates adenosine A(2A) receptor cell surface expression levels.
    Buira SP; Albasanz JL; Dentesano G; Moreno J; Martín M; Ferrer I; Barrachina M
    J Neurochem; 2010 Mar; 112(5):1273-85. PubMed ID: 20002525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 1,3,5-triazine as adenosine A
    Masih A; Agnihotri AK; Srivastava JK; Pandey N; Bhat HR; Singh UP
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22659. PubMed ID: 33156955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupancy of adenosine A
    Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
    Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A
    Waggan I; Rissanen E; Tuisku J; Joutsa J; Helin S; Parkkola R; Rinne JO; Airas L
    J Neurol; 2023 Jan; 270(1):300-310. PubMed ID: 36053386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
    Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients.
    Vincenzi F; Corciulo C; Targa M; Casetta I; Gentile M; Granieri E; Borea PA; Popoli P; Varani K
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):406-13. PubMed ID: 23679925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting adenosine A2A receptors in Parkinson's disease.
    Schwarzschild MA; Agnati L; Fuxe K; Chen JF; Morelli M
    Trends Neurosci; 2006 Nov; 29(11):647-54. PubMed ID: 17030429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A(2A) adenosine receptor binding parameters in platelets from patients affected by pathological gambling.
    Martini C; Daniele S; Picchetti M; Panighini A; Carlini M; Trincavelli ML; Cesari D; Da Pozzo E; Golia F; Dell'Osso L
    Neuropsychobiology; 2011; 63(3):154-9. PubMed ID: 21228607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.
    Kulisevsky J; Poyurovsky M
    Eur Neurol; 2012; 67(1):4-11. PubMed ID: 22134373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists.
    Pinna A; Wardas J; Simola N; Morelli M
    Life Sci; 2005 Nov; 77(26):3259-67. PubMed ID: 15979104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson's disease.
    Uchida S; Kadowaki-Horita T; Kanda T
    Int Rev Neurobiol; 2014; 119():169-89. PubMed ID: 25175966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.